72 Biggest Movers From Yesterday

Gainers

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) shares surged 72.9% to close at $8.11 on Wednesday. On Tuesday, Protagonist Therapeutics announced results from mid-stage study of PTG-300 in transfusion-dependent beta-thalassemia.
Ibio Inc (NYSE:IBIO) shares jumped 51.1% to close at $0.2840 on continued momentum after the company joined the manufacturing USA's tissue Biofabrication initiative.
Kodiak Sciences Inc. (NASDAQ:KOD) jumped 49.2% to close at $73.41. Kodiak Sciences priced 6 million share public offering of common stock at $46 per share.
Allakos Inc. (NASDAQ:ALLK) gained 43.6% to close at $137.73 following reports stating the company is weighing a potential sale.
Relmada Therapeutics, Inc. (NASDAQ:RLMD) rose 36.9% to close at $47.18. Relmada Therapeutics priced its common-stock offering of 3.33 million shares at $30 per share. The company expects to raise gross proceeds of $100 million from the offering, which is expected to close Dec. 6.
Anavex Life Sciences Corp. (NASDAQ:AVXL) gained 28.4% to close at $3.03. Anavex Life Sciences will present ANAVEX 2-73 data at 12th Clinical Trials on Alzheimer's Disease 2019 Conference.
Applied Therapeutics, Inc. (NASDAQ:APLT) shares climbed 21.7% to close at $24.00.
La Jolla Pharmaceutical Company (NASDAQ:LJPC) gained 19.6% to close at $3.35.
Sequans Communications S.A. (NYSE:SQNS) jumped 19% to close at $2.76.
Synthorx, Inc. (NASDAQ:THOR) gained 18.7% to close at $21.45.
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) rose 17.9% to close at $6.72.
Pacific Drilling S.A. (NYSE:PACD) climbed 16.9% to close at $3.05
Can-Fite BioPharma Ltd. (NYSE:CANF) gained 16.7% to close at $4.40.
California Resources Corporation (NYSE:CRC) rose 16.5% to close at $7.68.
DarioHealth Corp. (NASDAQ:DRIO) rose 16.2% to close at $8.68.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) surged 15.6% to close at $8.25.
Vista Oil & Gas, S.A.B. de C.V. (NYSE:VIST) shares rose 15.4% to close at $6.74.
Capstone Turbine Corporation (NASDAQ:CPST) gained 15.3% to close at $3.8850.
Unique Fabricating, Inc. (NYSE:UFAB) shares gained 14.8% to close at $4.57.
Mustang Bio, Inc. (NASDAQ:MBIO) rose 14.8% to close at $3.88.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) gained 14.2% to close at $3.77 on continued momentum after the company announced it completed the initial stage for its Phase 2 clinical study of TELE-ABC.
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) rose 13.3% to close at $5.47.
Rubius Therapeutics, Inc. (NASDAQ:RUBY) gained 13.1% to close at $9.35.
Hudbay Minerals Inc. (NYSE:HBM) rose 12.7% to close at $3.56.
Whiting Petroleum Corporation (NYSE:WLL) climbed 12.5% to close at $5.05.
Cortexyme, Inc. (NASDAQ:CRTX) climbed 12.5% to close at $31.87.
ImmunoGen, Inc. (NASDAQ:IMGN) rose 12.4% to close at $4.00.
Hebron Technology Co., Ltd. (NASDAQ:HEBT) jumped 12.1% to close at $6.28.
Centennial Resource Development, Inc. (NASDAQ:CDEV) gained 11.8% to close at $3.36 following a larger-than-expected draw in US crude inventories as well as positive US-China trade reports and anticipation of further OPEC production cuts this year.
Jounce Therapeutics, Inc. (NASDAQ:JNCE) surged 11.7% to close at $7.90.
IGM Biosciences, Inc. (NASDAQ:IGMS) gained 11.6% to close at $22.21.
PG&E Corporation (NYSE:PCG) gained 11.2% to close at $9.47. Strength may be due to macro optimism after Bloomberg reported that a US-China trade deal is getting closer.
BridgeBio Pharma, Inc. (NASDAQ:BBIO) shares rose 11% to close at $33.92
Earthstone Energy, Inc. (NYSE:ESTE) jumped 10.7% to close at $4.77.
Endologix, Inc. (NASDAQ:ELGX) rose 10.7% to close at $2.5450.
Coda Octopus Group, Inc. (NASDAQ:CODA) climbed 10.6% to close at $8.07.
Valaris plc (NYSE:VAL) gained 10.5% to close at $4.43. Shares of oil companies are trading higher following a larger-than-expected draw in US crude inventories as well as positive US-China trade reports and anticipation of further OPEC production cuts this year.
Rapt Therapeutics Inc (NASDAQ:RAPT) gained 10.3% to close at $27.53 after the company announced a collaboration with Hanmi Pharmaceutical to develop and commercialize FLX475 in Asia. Rapt is set to receive $10 million upfront and $108 million total milestones.
Endo International plc (NASDAQ:ENDP) rose 10.3% to close at $5.51.
Transocean Ltd. (NYSE:RIG) climbed 10.3% to close at $5.36 following a larger-than-expected draw in US crude inventories as well as positive US-China trade reports and anticipation of further OPEC production cuts this year.
Solaris Oilfield Infrastructure, Inc. (NYSE:SOI) shares gained 10.1% to close at $11.57.
Express, Inc. (NYSE:EXPR) jumped 10.1% to close at $3.91.
ESSA Pharma Inc. (NASDAQ:EPIX) gained 10% to close at $5.60.
Front Yard Residential Corporation (NYSE:RESI) shares surged 9.9% to close at $12.71 following Bloomberg article 'Amherst is in talks to buy Front Yard after activist pressure.'
Avita Medical Limited (NASDAQ:RCEL) surged 9.2% to close at $8.56.
Tata Motors Limited ADR (NYSE:TTM) shares rose 8.3% to close at $11.85 after the company reported strong US Land Rover sales and announced it will be raising passenger vehicle prices starting in 2020.
Universal Technical Institute, Inc. (NYSE:UTI) shares rose 4.8% to close at $7.00. Argus Research upgraded Universal Technical from Sell to Hold.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Check out these big penny stock gainers and losers

Losers

Barnes & Noble Education, Inc. (NYSE:BNED) shares tumbled 20.8% to close at $3.80 on Wednesday after the company reported downbeat Q2 results.
Revance Therapeutics, Inc. (NASDAQ:RVNC) fell 17.6% to close at $16.61 after the company priced its 6.5 million share common stock offering at $17 per share.
Ardelyx, Inc. (NASDAQ:ARDX) shares dipped 15.3% to close at $6.82. Shares surged Tuesday following results from the company's Phase 3 PHREEDOM trial in chronic kidney disease patients
China Rapid Finance Limited (NYSE:XRF) shares dropped 15.1% to close at $1.91.
Kaleido BioSciences, Inc. (NASDAQ:KLDO) fell 13% to close at $7.30.
Akers Biosciences, Inc. (NASDAQ:AKER) dropped 11.4% to close at $5.50.
Acorda Therapeutics, Inc. (NASDAQ:ACOR) dipped 11.2% to close at $1.83.
Bicycle Therapeutics plc (NASDAQ:BCYC) fell 10.8% to close at $7.65.
Stage Stores, Inc. (NYSE:SSI) dipped 10.3% to close at $4.89.
NuCana plc (NASDAQ:NCNA) fell 9.5% to close at $6.73.
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) shares declined 9.2% to close at $10.05.
OrganiGram Holdings Inc. (NASDAQ:OGI) dipped 9.2% to close at $2.57 after the company announced at-the-market equity program.
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) fell 9% to close at $7.50.
Menlo Therapeutics Inc. (NASDAQ:MNLO) dipped 8.7% to close at $3.98.
ViewRay, Inc. (NASDAQ:VRAY) dropped 8.1% to close at $4.08 after the company priced its 41.55 million share common stock offering at $3.13 per share. B. Riley downgraded ViewRay from Buy to Neutral and lowered the price target from $9 to $5.
Instructure Inc (NYSE:INST) tumbled 8% to close at $48.75 after the company agreed to be acquired by Thoma Bravo for $47.60 per share in cash.
Evolus, Inc. (NASDAQ:EOLS) fell 7.8% to close at $12.70.
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) fell 7.5% to close at $4.67 after dropping 11.71% on Tuesday.
Dynatrace, Inc. (NYSE:DT) fell 7.4% to close at $25.01.
Myovant Sciences Ltd. (NYSE:MYOV) declined 7% to close at $17.32.
Luckin Coffee Inc. (NASDAQ:LK) dropped 6.6% to close at $29.84.
Zscaler Inc (NASDAQ:ZS) shares fell 5.6% to close at $49.85 despite reporting a first quarter earnings beat. The company issued weak second quarter earnings guidance.
Immunomedics, Inc. (NASDAQ:IMMU) fell 5.2% to close at $18.01 after the company announced a proposed offering of $250 million of common stock.
Workday, Inc. (NASDAQ:WDAY) fell 4.7% to close at $165.39 after the company reported Q3 earnings and issued Q4 and FY20 guidance. The company said it does not expect its recent Scout RFP acquisition to have a notable impact on subscription revenue until 2022.
Cannae Holdings Inc (NYSE:CNNE) shares fell 4% to close at $35.37. Cannae Holdings priced its upsized 6.5 million share public offering of common stock for gross proceeds of $214,500,000.